
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Intracellular Trafficking and Endosomal Release of Oligonucleotides: What We Know and What We Don’t
R. L. Juliano
Nucleic Acid Therapeutics (2018) Vol. 28, Iss. 3, pp. 166-177
Open Access | Times Cited: 109
R. L. Juliano
Nucleic Acid Therapeutics (2018) Vol. 28, Iss. 3, pp. 166-177
Open Access | Times Cited: 109
Showing 1-25 of 109 citing articles:
The dawn of mRNA vaccines: The COVID-19 case
R Verbeke, Ine Lentacker, Stefaan C. De Smedt, et al.
Journal of Controlled Release (2021) Vol. 333, pp. 511-520
Open Access | Times Cited: 391
R Verbeke, Ine Lentacker, Stefaan C. De Smedt, et al.
Journal of Controlled Release (2021) Vol. 333, pp. 511-520
Open Access | Times Cited: 391
Three decades of messenger RNA vaccine development
R Verbeke, Ine Lentacker, Stefaan C. De Smedt, et al.
Nano Today (2019) Vol. 28, pp. 100766-100766
Open Access | Times Cited: 257
R Verbeke, Ine Lentacker, Stefaan C. De Smedt, et al.
Nano Today (2019) Vol. 28, pp. 100766-100766
Open Access | Times Cited: 257
Delivery of Oligonucleotides to the Liver with GalNAc: From Research to Registered Therapeutic Drug
Alexandre J. Debacker, Jon Voutila, Matthew C. Catley, et al.
Molecular Therapy (2020) Vol. 28, Iss. 8, pp. 1759-1771
Open Access | Times Cited: 253
Alexandre J. Debacker, Jon Voutila, Matthew C. Catley, et al.
Molecular Therapy (2020) Vol. 28, Iss. 8, pp. 1759-1771
Open Access | Times Cited: 253
Phosphorothioate modified oligonucleotide–protein interactions
Stanley T. Crooke, Timothy A. Vickers, Xue‐hai Liang
Nucleic Acids Research (2020) Vol. 48, Iss. 10, pp. 5235-5253
Open Access | Times Cited: 247
Stanley T. Crooke, Timothy A. Vickers, Xue‐hai Liang
Nucleic Acids Research (2020) Vol. 48, Iss. 10, pp. 5235-5253
Open Access | Times Cited: 247
Investigating the pharmacodynamic durability of GalNAc–siRNA conjugates
Christopher R. Brown, Swati Gupta, June Qin, et al.
Nucleic Acids Research (2020) Vol. 48, Iss. 21, pp. 11827-11844
Open Access | Times Cited: 213
Christopher R. Brown, Swati Gupta, June Qin, et al.
Nucleic Acids Research (2020) Vol. 48, Iss. 21, pp. 11827-11844
Open Access | Times Cited: 213
Barriers and Strategies of Cationic Liposomes for Cancer Gene Therapy
Chunyan Liu, Ligang Zhang, Wenhui Zhu, et al.
Molecular Therapy — Methods & Clinical Development (2020) Vol. 18, pp. 751-764
Open Access | Times Cited: 176
Chunyan Liu, Ligang Zhang, Wenhui Zhu, et al.
Molecular Therapy — Methods & Clinical Development (2020) Vol. 18, pp. 751-764
Open Access | Times Cited: 176
Imaging small molecule-induced endosomal escape of siRNA
Hampus Du Rietz, Hampus Hedlund, Sten Wilhelmson, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 143
Hampus Du Rietz, Hampus Hedlund, Sten Wilhelmson, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 143
Delivery of Oligonucleotide Therapeutics: Chemical Modifications, Lipid Nanoparticles, and Extracellular Vesicles
Jeremy Bost, Hanna M. G. Barriga, Margaret N. Holme, et al.
ACS Nano (2021) Vol. 15, Iss. 9, pp. 13993-14021
Open Access | Times Cited: 128
Jeremy Bost, Hanna M. G. Barriga, Margaret N. Holme, et al.
ACS Nano (2021) Vol. 15, Iss. 9, pp. 13993-14021
Open Access | Times Cited: 128
Absorption, Distribution, Metabolism, and Excretion of US Food and Drug Administration–Approved Antisense Oligonucleotide Drugs
Julia M. Migliorati, Sunna Liu, Anna Liu, et al.
Drug Metabolism and Disposition (2022) Vol. 50, Iss. 6, pp. 888-897
Open Access | Times Cited: 74
Julia M. Migliorati, Sunna Liu, Anna Liu, et al.
Drug Metabolism and Disposition (2022) Vol. 50, Iss. 6, pp. 888-897
Open Access | Times Cited: 74
Delivery of RNA Therapeutics: The Great Endosomal Escape!
Steven F. Dowdy, Ryan L. Setten, Xian-Shu Cui, et al.
Nucleic Acid Therapeutics (2022) Vol. 32, Iss. 5, pp. 361-368
Open Access | Times Cited: 74
Steven F. Dowdy, Ryan L. Setten, Xian-Shu Cui, et al.
Nucleic Acid Therapeutics (2022) Vol. 32, Iss. 5, pp. 361-368
Open Access | Times Cited: 74
Endosomal escape of RNA therapeutics: How do we solve this rate-limiting problem?
Steven F. Dowdy
RNA (2023) Vol. 29, Iss. 4, pp. 396-401
Open Access | Times Cited: 63
Steven F. Dowdy
RNA (2023) Vol. 29, Iss. 4, pp. 396-401
Open Access | Times Cited: 63
RNA‐PROTACs: Degraders of RNA‐Binding Proteins
Alice Ghidini, Antoine Cléry, François Halloy, et al.
Angewandte Chemie International Edition (2020) Vol. 60, Iss. 6, pp. 3163-3169
Open Access | Times Cited: 138
Alice Ghidini, Antoine Cléry, François Halloy, et al.
Angewandte Chemie International Edition (2020) Vol. 60, Iss. 6, pp. 3163-3169
Open Access | Times Cited: 138
Clinical significance of miRNAs in autoimmunity
Lian Zhang, Haijing Wu, Ming Zhao, et al.
Journal of Autoimmunity (2020) Vol. 109, pp. 102438-102438
Closed Access | Times Cited: 86
Lian Zhang, Haijing Wu, Ming Zhao, et al.
Journal of Autoimmunity (2020) Vol. 109, pp. 102438-102438
Closed Access | Times Cited: 86
Modified Nucleic Acids: Expanding the Capabilities of Functional Oligonucleotides
Steven Ochoa, Valeria T. Milam
Molecules (2020) Vol. 25, Iss. 20, pp. 4659-4659
Open Access | Times Cited: 86
Steven Ochoa, Valeria T. Milam
Molecules (2020) Vol. 25, Iss. 20, pp. 4659-4659
Open Access | Times Cited: 86
Antisense drug discovery and development technology considered in a pharmacological context
Stanley T. Crooke, Xue‐hai Liang, Rosanne M. Crooke, et al.
Biochemical Pharmacology (2020) Vol. 189, pp. 114196-114196
Closed Access | Times Cited: 72
Stanley T. Crooke, Xue‐hai Liang, Rosanne M. Crooke, et al.
Biochemical Pharmacology (2020) Vol. 189, pp. 114196-114196
Closed Access | Times Cited: 72
From Antisense RNA to RNA Modification: Therapeutic Potential of RNA-Based Technologies
Hironori Adachi, Martin Hengesbach, Yi‐Tao Yu, et al.
Biomedicines (2021) Vol. 9, Iss. 5, pp. 550-550
Open Access | Times Cited: 58
Hironori Adachi, Martin Hengesbach, Yi‐Tao Yu, et al.
Biomedicines (2021) Vol. 9, Iss. 5, pp. 550-550
Open Access | Times Cited: 58
Small non-coding RNA therapeutics for cardiovascular disease
Ajay M. Shah, Mauro Giacca
European Heart Journal (2022) Vol. 43, Iss. 43, pp. 4548-4561
Open Access | Times Cited: 55
Ajay M. Shah, Mauro Giacca
European Heart Journal (2022) Vol. 43, Iss. 43, pp. 4548-4561
Open Access | Times Cited: 55
Drug Discovery Perspectives of Antisense Oligonucleotides
Yeonjoon Kim
Biomolecules & Therapeutics (2023) Vol. 31, Iss. 3, pp. 241-252
Open Access | Times Cited: 26
Yeonjoon Kim
Biomolecules & Therapeutics (2023) Vol. 31, Iss. 3, pp. 241-252
Open Access | Times Cited: 26
Between hope and reality: treatment of genetic diseases through nucleic acid-based drugs
Virginie Baylot, Thi Khanh Le, David Taïeb, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 10
Virginie Baylot, Thi Khanh Le, David Taïeb, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 10
Pluronic-based nanovehicles: Recent advances in anticancer therapeutic applications
Ivana Jarak, Carla Varela, E. J. Tavares da Silva, et al.
European Journal of Medicinal Chemistry (2020) Vol. 206, pp. 112526-112526
Closed Access | Times Cited: 61
Ivana Jarak, Carla Varela, E. J. Tavares da Silva, et al.
European Journal of Medicinal Chemistry (2020) Vol. 206, pp. 112526-112526
Closed Access | Times Cited: 61
A critical analysis of methods used to investigate the cellular uptake and subcellular localization of RNA therapeutics
Kirsten Deprey, Nefeli Batistatou, Joshua A. Kritzer
Nucleic Acids Research (2020) Vol. 48, Iss. 14, pp. 7623-7639
Open Access | Times Cited: 55
Kirsten Deprey, Nefeli Batistatou, Joshua A. Kritzer
Nucleic Acids Research (2020) Vol. 48, Iss. 14, pp. 7623-7639
Open Access | Times Cited: 55
Therapeutic RNA Strategies for Chronic Obstructive Pulmonary Disease
Dan Mei, W.S. Daniel Tan, Yvonne Tay, et al.
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 7, pp. 475-486
Closed Access | Times Cited: 53
Dan Mei, W.S. Daniel Tan, Yvonne Tay, et al.
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 7, pp. 475-486
Closed Access | Times Cited: 53
Glucagon Like Peptide 1 Receptor Agonists for Targeted Delivery of Antisense Oligonucleotides to Pancreatic Beta Cell
Laurent Knerr, Thazha P. Prakash, Richard Lee, et al.
Journal of the American Chemical Society (2021) Vol. 143, Iss. 9, pp. 3416-3429
Closed Access | Times Cited: 52
Laurent Knerr, Thazha P. Prakash, Richard Lee, et al.
Journal of the American Chemical Society (2021) Vol. 143, Iss. 9, pp. 3416-3429
Closed Access | Times Cited: 52
Site-directed RNA editing: recent advances and open challenges
Hamid R. Mansouri, Michael F. Jantsch
RNA Biology (2021) Vol. 18, Iss. sup1, pp. 41-50
Open Access | Times Cited: 49
Hamid R. Mansouri, Michael F. Jantsch
RNA Biology (2021) Vol. 18, Iss. sup1, pp. 41-50
Open Access | Times Cited: 49
Innovative developments and emerging technologies in RNA therapeutics
François Halloy, Annabelle Biscans, Katherine E. Bujold, et al.
RNA Biology (2022) Vol. 19, Iss. 1, pp. 313-332
Open Access | Times Cited: 33
François Halloy, Annabelle Biscans, Katherine E. Bujold, et al.
RNA Biology (2022) Vol. 19, Iss. 1, pp. 313-332
Open Access | Times Cited: 33